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Abstract: Cocaine addiction is characterized by a persistently heightened 
susceptibility to drug relapse. For this reason, the identification of medications 
that prevent drug relapse is a critical goal of drug abuse research. Drug re-
exposure, the onset of stressful life events, and exposure to cues previously 
associated with drug use have been identified as determinants of relapse in 
humans and have been found to reinstate extinguished cocaine seeking in 
rats. This study examined the effects of acute oral (gavage) administration of 
levo-tetrahydropalmatine (l-THP), a tetrahydroprotoberberine isoquinoline 
with a pharmacological profile that includes antagonism of D1, D2 and D3 
dopamine receptors, on the reinstatement of extinguished cocaine seeking by 
a cocaine challenge (10 mg/kg, ip), a stressor (uncontrollable electric 
footshock [EFS]) or response-contingent exposure to a stimulus (tone and 
light complex) previously associated with drug delivery in male Sprague-
Dawley rats. Extinguished drug seeking was reinstated by ip cocaine, EFS, or 
response-contingent presentation of drug-associated cues in vehicle-
pretreated rats following extinction of iv cocaine self-adminisration. Oral 
administration of either 3.0 or 10.0 mg/kg l-THP one hour prior to 
reinstatement testing significantly attenuated reinstatement by each of the 
stimuli. Food-reinforced responding and baseline post-extinction responding 
were significantly attenuated at the 10.0, but not the 3.0 mg/kg, l-THP dose, 
indicating that the effects of 3 mg/kg l-THP on reinstatement were likely 
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independent of non-specific motor impairment. These findings further suggest 
that l-THP may have utility for the treatment of cocaine addiction. 
Keywords: relapse, dopamine, THP, craving, cocaine, reinstatement 
1. Introduction 
The unpredictable relapse of drug use that occurs even after 
extended periods of drug abstinence is the primary obstacle to the 
effective management of cocaine addiction. Although a number of 
factors likely contribute to relapse, drug re-exposure, the onset of 
stressful life events, and exposure to cues previously associated with 
drug self-administration are among the most important determinants 
of drug use. Relapse precipitated by each of these stimuli can be 
studied in rats using the self-administration/reinstatement approach 
(de Wit and Stewart, 1981; Erb et al., 1996; Meil and See, 1996; 
Ahmed and Koob, 1997). 
Although a number of potentially promising medications have 
been identified for treating drug-dependent individuals (Vocci et al., 
2005), a demand exists for new and more effective medicinal 
approaches, particularly those that target drug craving and relapse 
(O’Brien, 2005). Despite their potential efficacy, traditional herbal 
preparations are often not considered to be viable options for treating 
drug addiction, due in part to the limited number of reliable clinical 
and preclinical studies examining their utility. However, there has been 
a recent effort by many to test the effectiveness of such agents and 
their active constituents using accepted preclinical disease models and 
well-controlled clinical trials (Ernst, 2005; Lu et al., 2009). 
Tetrahydropalmatine (THP) is a tetrahydroprotoberberine 
(THPB) isoquinoline alkaloid and a primary active constituent of herbal 
preparations containing plant species of the genera Stephania 
(Menispermaceae family) and Corydalis (Fumariaceae family), 
including Bin Ju Huan, Yan Hu Suo, Di Bu Long and Hua Jian Jiu Teng. 
Two of these species, Corydalis ambigua (yan hu suo) and Stephania 
tetranda (fang ji) are among the 50 fundamental herbs in Chinese 
herbology and have been used traditionally for their sedative, 
neuroleptic and analgesic properties (Ding, 1987). In particular, the 
levo isomer of THP (l-THP) appears to contribute to many of the 
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therapeutic effects of these preparations, presumably through its 
interactions with dopamine (DA) receptors (Jin, 1987; Chu et al., 
2008). 
A large body of data, including our own preliminary analyses, 
indicates that l-THP is an antagonist at DA D1 and D2 receptors (D1R, 
D2R; Jin, 1987; Guo et al., 1997; Mantsch et al., 2007; Huang and 
Jin, 1992; Hu and Jin, 1999; Jin et al., 1986; Sun et al., 1992; Wu et 
al., 1990; Xu et al., 1989; Zhu et al., 1991). Considering the 
involvement of dopaminergic neurotransmission in drug addiction and 
relapse (Volkow et al., 2004; Anderson and Pierce, 2005), compounds 
such as l-THP which antagonize DA receptors have long been thought 
to represent potential medications for the management of cocaine 
addiction. However, despite its promise, this approach has been 
largely unsuccessful due to lack of efficacy and/or the occurrence of 
use limiting side effects, attributable in part to undesirable 
pharmacological profiles that include high affinity antagonism of D2R 
(Platt et al., 2002). Compared to many other DA receptor antagonist 
drugs, l-THP has lower affinity for D2R relative to D1R (Jin, 1987). l-
THP also binds to D3 DA receptors (Mantsch et al., 2007), likely 
functioning as an antagonist, and has secondary actions at a number 
of non-DA receptors (Lu et al., 1996; Halbsguth et al., 2003). The 
unique pharmacological profile of l-THP distinguishes it from other DA 
antagonist drugs and may make it a more suitable medication for 
treating cocaine addiction. 
We and others have recently demonstrated that l-THP 
attenuates cocaine self-administration (SA; Mantsch et al., 2007; Xi et 
al., 2007), cocaine-evoked reinstatement (Mantsch et al., 2007), 
cocaine discrimination (Mantsch et al., 2010) and cocaine-induced 
reductions in intra-cranial self-stimulation (ICSS) thresholds (Xi et al., 
2007) in rats at doses that produce little or no impairment of motor 
function. Along with the findings of a recent preliminary clinical trial 
demonstrating that l-THP attenuates craving and relapse in recovering 
heroin addicts (Yang et al., 2008), these data suggest that further 
investigation of the utility of l-THP for the treatment of cocaine 
addiction is warranted. 
In the present study we investigated the ability of l-THP isolated 
from the roots of Stephania delavayi Diels (Di Bu Long) acquired from 
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Yunnan province in China, when administered orally by gavage, to 
block reinstatement of extinguished drug-seeking behavior by drug re-
exposure, stress, and the presentation of drug-associated cues. In an 
attempt to further dissociate l-THP’s effects on reinstatement from its 
sedative/motor effects, we also examined the effects of orally 
administered l-THP on food-reinforced lever pressing in a separate 
group of rats and on baseline lever pressing following extinction. 
2. Methods 
2.1. Drugs 
Cocaine hydrochloride was obtained through the National 
Institute on Drug Abuse Drug Supply Program and was dissolved in 
0.9% NaCl. l-THP, isolated from the crushed and dried tuberous roots 
of Stephania delavayi Diels (Di Bu Long) grown in Yunnan province in 
China, was acquired from Guangxi Nanning Baihui Pharmaceutical 
Group (Nanning, Guangxi, China) via the Beijing Basic Science 
Research Institute (Beijing, China) and was dissolved in sterile water. 
The purity of the isolated l-THP, according to the manufacturer, was 
greater than 99% as determined using high performance liquid 
chromatography. 
2.2. Subjects 
A total of 44 adult male Sprague-Dawley rats (Harlan 
Laboratories, St. Louis, MO) weighing 325g – 350g at the start of the 
study were used. Rats were housed individually in a temperature- and 
humidity-controlled environment in an AAALAC-accredited animal 
facility under a 12 h/12 h reversed light/dark cycle (testing during the 
dark cycle). Availability of food was restricted to 20-25 g each day, a 
condition that maintains body weight at approximately 80-85% of 
free-feeding levels, in order to facilitate the acquisition of SA (De Vry 
et al., 1989). Notably, it has been reported that this level of chronic 
food restriction does not alter the reinstatement of extinguished 
cocaine-seeking behavior by cocaine, stress, or cocaine-assocaiated 
cues (Bongiovanni and See, 2008). Water was available at all times 
during the study, including in the SA chambers. All procedures were 
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carried out in accordance with the Guide for the Care and Use of 
Animals as adopted and promulgated by the NIH. 
2.3. Catheterization Surgery 
Rats were implanted with indwelling jugular catheters attached 
to a back-mounted guide cannula under ketamine (100 mg/kg, ip) and 
xylazine (2 mg/kg, ip) anesthesia and were allowed to recover for five 
days before SA, during which time they were provided acetaminophen 
(480 mg/l) in their drinking water. After implantation, rats were 
injected daily with an antibiotic, cefazolin (15 mg, iv). For SA, a 
polyurethane delivery line encased in a stainless-steel leash was 
connected to the cannula to permit infusion of drug from a 30-ml 
syringe mounted in a motor-driven syringe pump via a leak-proof 
swivel suspended above the chamber. The swivel-and-leash assembly 
was counterbalanced to permit relatively unrestrained movement 
within the chamber. Catheters were filled daily with heparin (83 IU/ml) 
and capped when the delivery line was disconnected. 
2.4. Effects of l-THP on cocaine- and EFS-induced 
reinstatement 
Fifteen total rats were tested for the effects of oral pretreatment 
with l-THP on reinstatement induced by cocaine (10 mg/kg) and a 
stressor, uncontrollable intermittent electric footshock (EFS). 
2.4.1. Cocaine SA  
Rats were initially trained to self-administer cocaine (1.0 
mg/kg/inf, iv) by pressing a lever under a fixed-ratio one (FR1) 
schedule during daily 2-h sessions, within which the active (i.e., front) 
lever was extended into the chamber and the corresponding stimulus 
light was illuminated. Pressing this lever resulted in an iv infusion of 
cocaine solution (200μl delivered over 5.0 s) followed by a 25-s time-
out period during which the stimulus light was extinguished but the 
lever remained extended. Responding on the second, inactive (i.e., 
back) lever was recorded but had no programmed consequences. Once 
stable and significant SA under the FR1 schedule was observed (i.e., > 
10 infusions), the response requirements for SA were gradually 
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increased to FR4. Once a stable response pattern was observed under 
the FR4 schedule (total responding < 10% variation from the mean 
over 3 consecutive sessions), rats were provided daily 6-h access to 
cocaine for SA under the FR4 schedule for 14 consecutive sessions 
prior to extinction. We have found that later reinstatement by cocaine 
or EFS is most pronounced following SA under these conditions 
(Mantsch et al., 2004; Mantsch et al., 2008). 
2.4.2. Extinction  
Extinction conditions were identical to those during SA, except 
that the extinction sessions only lasted for two hours and the cocaine 
solution was replaced with saline. Rats were tested daily for extinction 
until they emitted less than 15 responses during an extinction session 
or until they displayed stable patterns of low-level (<25 
responses/session) responding over two consecutive sessions, at 
which time they were tested for reinstatement. 
2.4.3. Cocaine- and EFS-Induced Reinstatement  
Each rat was tested twice for reinstatement following ip 
administration of 10 mg/kg cocaine and twice for reinstatement 
following EFS (four tests total: once following vehicle pretreatment and 
once following l-THP pretreatment for each stimulus). Separate groups 
of rats were used to test the effects of 3 mg/kg l-THP and 10 mg/kg l-
THP on reinstatement. We have found that prior testing for EFS-
induced reinstatement fails to alter subsequent cocaine-induced 
reinstatement and vice versa. Nonetheless, we counterbalanced the 
sequence of cocaine- and EFS-induced reinstatement testing such that 
half of the subjects received cocaine first and the other half received 
EFS first. Likewise, the sequence of vehicle and l-THP pretreatment 
was counterbalanced for each reinstating stimulus. Reinstatement 
sessions were identical to extinction sessions except that they were 
preceded by an ip cocaine injection or EFS and a pretreatment with l-
THP or vehicle. Cocaine-induced reinstatement testing consisted of ip 
administration of 10 mg/kg cocaine immediately prior to placing the 
rats into the chambers for the 2-h reinstatement session. EFS-induced 
reinstatement consisted of intermittent uncontrollable shocks through 
stainless steel grid floors of the SA/extinction/reinstatement test 
chambers for 10 minutes immediately prior to the 2-h reinstatement 
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session. Shocks (0.5 mA, 0.5 s duration) were delivered on an average 
of every 40 s (range 10 – 70) during the 10-min period within which 
the house light was on, both response levers were retracted and the 
stimulus lights were extinguished. Rats were treated with l-THP or 
vehicle by oral gavage one hr prior to each reinstatement test session. 
Reinstatement test sessions were separated by additional extinction 
training. Rats were required to exhibit responding within 10% of 
earlier extinction levels before the next reinstatement test. 
2.5. Cue-Induced Reinstatement 
A total of 20 rats were assigned to the cue-induced 
reinstatement experiment. For this experiment, rats were tested under 
SA, extinction, and reinstatement conditions similar to those 
previously reported (Meil and See, 1996; See et al., 2001) with the 
exception that cocaine during the SA sessions and response-contingent 
cues during the reinstatement sessions were delivered under a FR4 
schedule of reinforcement. 
2.5.1. Cocaine SA  
For these rats, cocaine SA training and testing were similar to 
the conditions described above except that: 1) SA sessions during the 
test phase only lasted two hours, 2) the stimulus light above the 
cocaine lever was extinguished at the start of the session and 3) each 
cocaine infusion self-administered under the FR4 schedule was paired 
with the concurrent presentation of a 5-s auditory/visual compound 
stimulus consisting of illumination of the stimulus light above the drug 
lever and a 78 dB, 2 kHz tone. After the SA training criteria were 
reached, rats were tested for SA under these conditions for an 
additional 14 days prior to extinction training. 
2.5.2. Extinction  
For these rats, extinction sessions were identical to the SA 
sessions except that lever pressing produced no consequences (i.e., no 
infusions or compound stimulus presentation). As described in Section 
2.4.2., rats were tested daily for extinction until they emitted less than 
15 responses during an extinction session or until they displayed 
stable patterns of low-level (<25 responses/session) responding over 
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two consecutive sessions at which time they were tested for 
reinstatement. 
2.5.3. Reinstatement  
Each rat was tested twice for cue-induced reinstatement (once 
following vehicle pretreatment and once following l-THP pretreatment 
for each stimulus). Half of the rats were tested first for reinstatement 
following administration of oral l-THP. The remaining rats were tested 
first for reinstatement following vehicle administration. Separate 
groups of rats were used to test the effects of 3 mg/kg l-THP and 10 
mg/kg l-THP on reinstatement. Reinstatement conditions were 
identical to those during extinction, except that responses on the 
previously active lever resulted in 5-sec presentations of the cocaine-
paired light-tone stimulus complex in the absence of cocaine 
reinforcement. Rats were treated with l-THP or vehicle by oral gavage 
one hr prior to each reinstatement test session. Reinstatement test 
sessions were separated by additional extinction training as described 
in section 2.4.3. 
2.6. Effects of l-THP on Baseline Post-Extinction 
Responding 
Since we did not design our reinstatement experiments to 
determine if l-THP altered lever pressing in the absence of a 
reinstating stimulus, nine rats were tested for the effects of oral l-THP 
(3 and 10 mg/kg) and vehicle on baseline responding following 
extinction. These rats were randomly selected from the rats used to 
determine the effects of l-THP on cocaine- and EFS-induced 
reinstatement and were tested under the extinction conditions 
described above (Section 2.4.2.) after reinstatement testing was 
complete. Each rat was tested for the effects of l-THP (3 and 10 
mg/kg) or vehicle administered orally one hour prior to the extinction 
session in counterbalanced sequence. Rats were required to display 
stable patterns of responding prior to testing (total responding < 10% 
variation from the mean over 3 consecutive sessions) and were 
required to exhibit responding within 10% of the earlier 3-day mean 
before the next test. 
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2.7. Effects of l-THP on Food-Reinforced Responding 
To further examine the potential role of sedation-related motor 
impairment in the effects of l-THP on reinstatement, the effects of oral 
l-THP administration (0, 3, and 10 mg/kg) on food-reinforced lever 
pressing was examined in a separate group of rats trained to self-
administer 45 mg sucrose-sweetened food pellets (Noyes Precision 
Pellets, Formula F; Research Diets, New Brunswick, NJ) under an FR4 
schedule of reinforcement during daily 30-min sessions. Food 
availability was indicated by illumination of a stimulus light above the 
lever. Once stable patterns of lever pressing were observed (total 
responding < 10% variation from the mean over 3 consecutive 
sessions), rats were tested for the effects of oral l-THP (3 or 10 
mg/kg) or vehicle, administered one hr before a food session, on 
responding. Each rat was tested with each l-THP dose and vehicle in 
counterbalanced sequence. Rats were required to display stable 
response patterns (within 10% of the earlier 3-day mean) prior to 
testing with the next l-THP dose or vehicle. 
2.8. Statistical Analyses 
All statistical analyses were conducted using PASW (Predictive 
Analytics SoftWare) statistics software (SPSS, Inc.). The effects l-THP 
on reinstatement by each of the three stimuli (cocaine, stress and 
cues) were initially examined using 3-way (reinstatement × l-THP 
treatment × l-THP dose) ANOVA with reinstatement and l-THP 
treatment as within subjects measures and dose as a between 
subjects measure. These analyses were followed by 2-way 
(reinstatement × l-THP) repeated measures ANOVA at each l-THP dose 
for each stimulus. Post-hoc testing consisted of Bonferroni-corrected t-
tests. One-way ANOVA (vehicle, 3 and 10 mg/kg l-THP) followed by 
post-hoc testing using Bonferroni-corrected t-tests was used to 
examine the effects of l-THP on baseline post-extinction and food-
reinforced responding. For all analyses, significance was defined as P 
<0.05. 
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3. Results 
3.1 Cocaine SA and Extinction 
Five of the 35 total rats used for the SA/reinstatement 
experiments did not complete the study due to catheter failure, illness 
or death. The mean numbers of training sessions prior to the 
acquisition of SA and extinction sessions prior to the first 
reinstatement test for each group are shown in Table 1. 
 
3.2 Cocaine-induced reinstatement 
Seven rats were tested for the effects of 3 mg/kg l-THP and six 
rats were tested for the effects of 10 mg/kg l-THP on cocaine-induced 
reinstatement (Figure 1). A 3-way ANOVA was used to examine 
cocaine-induced reinstatement (cocaine vs. extinction; repeated 
measure) following pretreatment with vehicle or l-THP (repeated 
measure), at two oral l-THP doses (3 mg/kg and 10 mg/kg; between 
subjects measure). Significant main effects of cocaine administration 
(F1,11=13.611; P<0.01), and l-THP treatment (F1,11=13.001; P<0.01) 
but not l-THP dose (P=0.932) were observed, as was a significant 
interaction between l-THP treatment and cocaine-induced 
reinstatement (F1,11=;14.007; P<0.01). Significant l-THP dose × 
reinstatement or l-THP treatment × dose × reinstatement interactions 
were not observed. 
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Figure 1 l-THP attenuates cocaine-induced reinstatement. Data represent 
responses on the cocaine lever during the final 6-h cocaine SA session (SA), the 2-h 
extinction session prior to reinstatement testing (Ext), and the 2-h reinstatement test 
session prior to which a 10 mg/kg (ip) injection of cocaine (Coc) was administered in 
rats tested for reinstatement following oral delivery of vehicle or 3 mg/kg (1A; n=7) or 
10 mg/kg (1B; n=6) l-THP. Cocaine-induced reinstatement was observed following 
vehicle but not l-THP pretreatment (*P<0.05 vs. Ext) and l-THP pretreated rats 
displayed significantly less cocaine-induced reinstatement compared to Veh controls 
(#P<0.05 vs. Veh). 
To further examine the effects of l-THP on cocaine-induced 
reinstatement, 2-way cocaine reinstatement × l-THP pretreatment 
ANOVAs were used for each dose group. In rats pretreated with the 3 
mg/kg l-THP dose (Figure 1A), significant main effects of both cocaine 
administration (F1,6=6.621; P<0.05) and l-THP treatment 
(F1,6=10.354; P<0.05) were observed, as was an l-THP × cocaine 
reinstatement interaction (F1,6=6.316; P<0.05). Post-hoc testing 
revealed that significant cocaine-induced reinstatement was observed 
in vehicle but not 3 mg/kg l-THP treated rats and was significantly 
reduced in rats pretreated with 3 mg/kg l-THP compared to rats 
pretreated with vehicle (P<0.05). In rats pretreated with the 10 mg/kg 
l-THP dose (Figure 1B), a significant main effect of cocaine 
administration (F1,5=8.188; P<0.05) but not 10 mg/kg l-THP treatment 
(P=0.106) was observed, as was a 10 mg/kg l-THP × cocaine 
reinstatement interaction (F1,5=11.443; P<0.05). Once again, post-hoc 
testing showed that significant cocaine-induced reinstatement was 
observed in vehicle but not 10 mg/kg l-THP treated rats and was 
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significantly reduced in rats pretreated with 10 mg/kg l-THP compared 
to rats pretreated with vehicle (P<0.05). 
3.3 Stress-induced reinstatement 
Seven rats were tested for the effects of 3 mg/kg l-THP and six 
rats were tested for the effects of 10 mg/kg l-THP on stress- (EFS-) 
induced reinstatement (Figure 2). A 3-way ANOVA was used to 
examine stress-induced reinstatement (EFS vs. extinction; repeated 
measure) following pre-treatment with vehicle or l-THP (repeated 
measure), at two l-THP doses (3 mg/kg and 10 mg/kg; between 
subjects measure). Significant overall main effects of stress 
(F1,11=11.171; P<0.01), and l-THP treatment (F1,11=9.552; P=0.01) 
but not l-THP dose (P=0.932) were observed, as was a significant 
interaction between l-THP treatment and stress-induced reinstatement 
(F1,11=11.442; P<0.01). Significant l-THP dose × reinstatement or l-
THP treatment × dose × reinstatement interactions were not 
observed. 
 
Figure 2 l-THP attenuates the reinstatement of extinguished cocaine seeking by a 
stressor, uncontrollable electric footshock (EFS), delivered intermittently prior to the 
test session. Data represent responses on the cocaine lever during the final 6-h 
cocaine SA session (SA), the 2-h extinction session prior to reinstatement testing 
(Ext), and the 2-h reinstatement test session (EFS) in rats tested for reinstatement 
following oral administration of vehicle or 3 mg/kg (2A; n=7) or 10 mg/kg (2B; n=6) 
l-THP. EFS reinstated cocaine seeking following vehicle but not l-THP pretreatment 
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(*P<0.05 vs. Ext) and l-THP pretreated rats displayed significantly less EFS-induced 
cocaine seeking compared to Veh controls (#P<0.05 vs. Veh). 
To more closely examine the effects of l-THP on stress-induced 
reinstatement, 2-way stress-induced reinstatement × l-THP 
pretreatment ANOVAs were used for each dose group. In rats 
pretreated with the 3 mg/kg l-THP dose (Figure 2A), significant main 
effects of both stress (F1,6=10.338; P<0.05) and 3 mg/kg l-THP 
treatment (F1,6=12.946; P<0.05) were observed, as was a 3 mg/kg l-
THP × stress-induced reinstatement interaction (F1,6=7.396; P<0.05). 
Post-hoc testing revealed that significant EFS-induced reinstatement 
was observed in vehicle but not 3 mg/kg l-THP treated rats and that 
stress-induced reinstatement was significantly reduced in rats 
pretreated with 3 mg/kg l-THP compared to rats pretreated with 
vehicle (P<0.05). In rats pretreated with the 10 mg/kg l-THP dose 
(Figure 2B), a significant 10 mg/kg l-THP × stress-induced 
reinstatement interaction (F1,5=7.545; P<0.05) but no significant main 
effect of EFS or 10 mg/kg l-THP treatment was observed. Once again, 
post-hoc testing showed that significant stress-induced reinstatement 
was observed in vehicle but not 10 mg/kg l-THP treated rats and that 
stress-induced reinstatement was significantly reduced in rats 
pretreated with 10 mg/kg l-THP compared to rats pretreated with 
vehicle (P<0.05). 
3.4 Cue-induced reinstatement 
Ten rats were tested for the effects of 3 mg/kg l-THP and seven 
rats were tested for the effects of 10 mg/kg l-THP on cue-induced 
reinstatement (Figure 3). A 3-way ANOVA was used to examine cue-
induced reinstatement (cue vs. extinction; repeated measure) 
following pre-treatment with vehicle or l-THP (repeated measure), at 
two l-THP doses (3 mg/kg and 10 mg/kg; between subjects measure). 
Significant main effects of cue presentation (F1,15=11.512; P<0.01), 
and l-THP treatment (F1,15=14.983; P<0.01) but not l-THP dose 
(P=0.247) were observed, as was a significant interaction between l-
THP treatment and cue-induced reinstatement 
(F1,15=20.674;P<0.001). Significant l-THP dose × cue reinstatement or 
l-THP treatment × dose × cue reinstatement interactions were not 
observed. 
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Figure 3 l-THP prevents the reinstatement of extinguished cocaine seeking by 
response contingent presentation of cues (tone-light complex) previously associated 
with cocaine SA. Data represent responses on the cocaine lever during the final 2-h 
cocaine SA session (SA), the 2-h extinction session prior to reinstatement testing 
(Ext), and the 2-h reinstatement test session (Cue) in rats tested for reinstatement 
following oral administration of vehicle or 3 mg/kg (3A; n=10) or 10 mg/kg (3B; n=7) 
l-THP. Cue presentation reinstated cocaine seeking following vehicle but not l-THP 
pretreatment (*P<0.05 vs. Ext) and l-THP pretreated rats displayed significantly less 
cue-induced cocaine seeking compared to Veh controls (#P<0.05 vs. Veh). 
As described above, to further examine the effects of l-THP on 
cue-induced reinstatement, 2-way cue-induced reinstatement × l-THP 
pretreatment ANOVAs were used for each dose group. In rats 
pretreated with the 3 mg/kg l-THP dose (Figure 3A), significant main 
effects of both cue presentation (F1,9=11.144; P<0.01) and l-THP 
treatment (F1,9=8.433; P<0.05) were observed, as was an l-THP × cue 
presentation interaction (F1,9=10.968; P<0.01). Post-hoc testing 
revealed that significant cue-induced reinstatement was observed in 
vehicle but not l-THP treated rats and was significantly reduced in rats 
pretreated with l-THP compared to rats pretreated with vehicle 
(P<0.05). In rats pretreated with the 10 mg/kg l-THP dose (Figure 
3B), significant main effects of cue presentation (F1,6=6.559; P<0.05) 
but not 10 mg/kg l-THP treatment (P=0.156) were observed, as was a 
10 mg/kg l-THP × cue presentation interaction (F1,6=9.176; P<0.05). 
Post-hoc testing revealed that significant cue-induced reinstatement 
was observed in vehicle but not 10 mg/kg l-THP treated rats and was 
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significantly reduced in rats pretreated with 10 mg/kg l-THP compared 
to rats pretreated with vehicle (P<0.05). 
3.5 Effects on baseline post-extinction responding 
Since our original reinstatement design did not include testing 
for the effects of l-THP on baseline extinction responding, an additional 
nine rats were tested for the effects of 3 and 10 mg/kg l-THP on 
responding during an extinction session in order to determine if l-THP 
induced reductions in reinstatement may have been attributable to 
non-specific impairment of the ability of the rats to press the lever 
(Figure 4). Although one-way repeated measures ANOVA failed to 
show a significant effect of l-THP on responding (P=0.058), lever 
pressing was markedly reduced in rats following administration of the 
10 mg/kg l-THP dose. Post-hoc testing using Bonferroni-correct t-tests 
revealed that responding after administration of 10 mg/kg l-THP was 
significantly reduced compared to responding following administration 
of 3 mg/kg l-THP (P<0.05) but not vehicle (P=0.173). 
 
Figure 4 Effects of l-THP on baseline extinction responding. Lever pressing during 
the 2-h session was significantly reduced by oral administration of 10 mg/kg l-THP 
compared to 3 mg/kg l-THP but not vehicle (V; *P<0.05). No effects of 3 mg/kg l-THP 
were found. 
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3.6 Food-reinforced lever pressing 
To further test if l-THP induced reductions in reinstatement may 
have been attributable to non-specific motor impairment, the effects of 
oral l-THP on food-reinforced lever pressing were examined in eight 
rats trained to self-administer sucrose-sweetened food pellets under a 
FR4 schedule of reinforcement and are shown in Figure 5. One-way 
repeated measures ANOVA showed a significant effect of l-THP on 
food-reinforced responding (F2,14=12.315; P=0.001). Post-hoc testing 
using a Bonferroni-corrected t-test showed that responding was 
significantly attenuated following oral administration of the 10 mg/kg, 
but not 3 mg/kg, l-THP dose (P<0.05). 
 
Figure 5 Effects of l-THP on food-reinforced lever pressing. Food- (sucrose-
sweetened pellet-) reinforced lever pressing under a FR4 schedule during 30 min 
sessions was significantly reduced by oral administration of 10 mg/kg but not 3 mg/kg 
l-THP (*P<0.001 vs. V). 
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4. Discussion 
4.1 Summary of findings 
We and others have previously reported that ip administration 
of l-THP attenuates cocaine SA under both FR and PR (progressive 
ratio) schedules (Mantsch et al., 2007; Xi et al., 2007; Mantsch et al., 
2010), cocaine-induced reductions in ICSS thresholds (Xi et al., 2007), 
cocaine discrimination (Mantsch et al., 2010) and cocaine-induced 
reinstatement of extinguished cocaine-seeking behavior (Mantsch et 
al., 2007). This paper extends these findings by demonstrating that l-
THP, administered orally, also attenuates cocaine-induced 
reinstatement, as well as reinstatement by a stressor (uncontrollable 
EFS) or response-contingent delivery of conditioned cues previous 
paired with cocaine SA. In each case, l-THP decreased reinstatement 
at a dose (3 mg/kg) that failed to alter food-reinforced lever pressing 
or baseline post-extinction responding, suggesting that l-THP-induced 
decreases in cocaine seeking were likely not secondary to non-specific 
motor impairment by l-THP. 
4.2. l-THP as an anti-craving/anti-relapse agent 
The sudden and often unpredictable relapse of drug use after 
extended periods of abstinence continues to pose a major challenge to 
the effective treatment of cocaine addiction. For this reason, the 
identification and development of medications aimed at preventing 
relapse through the targeting of neurobiological pathways that underlie 
drug craving continues to be a high priority for addiction researchers 
(O’Brien, 2005). Although the ability of the reinstatement approach to 
predict effective anti-craving medications remains a matter of debate 
(Epstein et al., 2006; Yahyavi-Firouz-Abadi and See, 2009), our 
findings that l-THP, when administered orally, attenuates 
reinstatement by cocaine re-exposure, presentation of drug-associated 
cues, or stress, three of the primary precipitating factors of craving in 
human addicts, while at the same time attenuating the reinforcing 
effects of cocaine (Mantsch et al., 2007; Xi et al., 2007; Mantsch et 
al., 2010), suggests that examination of the efficacy of l-THP in human 
populations may be justified. Accordingly, a recent preliminary clinical 
trial reported that l-THP reduces drug craving and relapse in 
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recovering heroin addicts (Yang et al., 2008). Clinical testing of l-THP 
effectiveness in the US awaits further examination of its safety for use 
in humans. 
4.3. Dopamine receptor antagonist properties of l-THP 
It is likely that the effects of l-THP on cocaine-seeking behavior 
are related to its antagonism of DA receptors. A large body of data, 
including our own preliminary analyses, indicates that l-THP is an 
antagonist at D1R and D2R (Jin, 1987; Guo et al., 1997; Mantsch et 
al., 2007; Huang and Jin, 1992; Hu and Jin, 1999; Jin et al., 1986; 
Sun et al., 1992; Wu et al., 1990; Xu et al., 1989; Zhu et al., 1991). 
Considering the involvement of dopaminergic neurotransmission in 
cocaine-seeking behavior (see Volkow et al., 2004; Anderson and 
Pierce, 2005 for reviews), compounds such as l-THP that antagonize 
DA receptors have long been thought to represent potential 
medications for the management of cocaine addiction. Compared to 
many other DA receptor antagonist drugs, l-THP has lower affinity for 
D2R relative to D1R (Jin, 1987). l-THP also binds to D3 DA receptors 
(Mantsch et al., 2007) at concentrations reached in the brain following 
oral administration of the doses tested in this study (Hong et al., 
2006), likely functioning as an antagonist; an effect that may 
contribute to its blockade of cocaine-mediated responses (Mantsch et 
al., 2010). The blockade of pre-synaptic autoreceptors by l-THP results 
in increased dopamine release (Marcenac et al., 1986) and it has been 
suggested that lower affinity of l-THP for D2R may confer some degree 
of autoreceptor selectivity (Jin et al., 1986). 
4.4. Dopamine receptors and relapse 
In addition to establishing l-THP as a potentially effective 
medication for the management of relapse, the present data suggest 
that DA may be a common mediator of relapse in response to stress, 
cocaine re-exposure, and exposure to cocaine-associated cues. These 
findings are consistent with a large body of literature implicating DA 
receptors in reinstatement (see Volkow et al., 2004; Anderson and 
Pierce, 2005 for reviews). DA receptor agonists (Khroyan et al., 2003; 
de Vries et al., 1999) and selective DA transport blockers (Schmidt 
and Pierce, 2006b; Schenk and Gettings, 2003) reinstate extinguished 
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cocaine seeking, while systemic administration of DA antagonists and 
low-efficacy agonists at D1, D2, and D3 DA receptors (D1R, D2R, and 
D3R) have been reported to attenuate drug seeking evoked by cocaine 
re-exposure (Khroyan et al., 2003: D1R; Khroyan et al., 2000: D1R 
and D2R; Schenk and Gettings, 2003: D2R; Vorel et al., 2002: D3R; Xi 
et al., 2005: D3R; Peng et al., 2009: D3R), presentation of cocaine-
associated cues (Ciccocioppo et al., 2001: D1R; Alleweireldt et al., 
2002: D1R; Feltenstein et al., 2007: D2R; Crombag et al., 2002: D1R 
and D2R; Cervo et al., 2003: D2/3R; Cervo et al., 2007:D3R; Di Ciano 
et al., 2003: D3R; Gilbert et al., 2005: D3R), and stress (Xi et al., 
2004; D3R). 
While DA may be involved in reinstatement in response to each 
of these stimuli, the neuroanatomical site of DA action appears to 
vary, depending on the reinstating stimulus. For example, DA 
activation of D1R in the amygdala, particularly the basolateral 
amygdala appears to play a critical role in cue-induced reinstatement 
(See et al., 2001; Alleweireldt et al., 2006), while prefrontal cortical 
D1R activation appears to be important for stress-induced 
reinstatement (McFarland et al., 2003; Capriles et al., 2003; Sanchez 
et al., 2003), and D1R and D2R activation in the nucleus accumbens 
shell (Anderson et al., 2003; 2006; Bachtell et al., 2005; Schmidt et 
al., 2006a; Schmidt and Pierce, 2006) as well as D1R activation in 
prefrontal cortical regions (McFarland et al., 2001; Sun and Rebec, 
2005) appears to be required for reinstatement in response to cocaine. 
Notably, high levels of cocaine intake such as those reached during the 
6-h sessions used for the rats tested for cocaine- and stress-induced 
reinstatement in the present study and often observed in cocaine 
addicts appears to recruit DA involvement in drug seeking in additional 
brain regions, such as the NA core (Madayag et al., 2010), further 
establishing the importance of the DA system as a target for 
pharmacotherapy. 
4.5. Effects of l-THP at non-DA receptors 
Our own preliminary binding analysis suggests that l-THP, at 
brain concentrations comparable to those that may be reached 
following oral l-THP delivery (Hong et al., 2006) also displays 
moderate binding to alpha-1 and alpha-2 adrenergic receptors as well 
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as strong binding to 5-HT1A receptors (Mantsch et al., 2007 and 
unpublished findings). l-THP is an antagonist at alpha-1 adrenergic 
receptors (Lu et al., 1996). The effects at alpha-2 adrenergic receptors 
are unclear; l-THP has been reported to both mimic (Wu and Jin, 
1995) and block (Liu et al., 1989) the effects of the alpha-2 adrenergic 
receptor agonist, clonidine. The actions of l-THP at 5-HT1A receptors 
(i.e., full agonist, partial agonist, vs. antagonist) have not been 
reported. It has also been found that l-THP has positive cooperative 
effects at the GABAA receptor (Halbsguth et al., 1996), an effect that 
may contribute to the high-dose behavioral suppressive effects of l-
THP (Xu et al., 1981). Despite its use as an analgesic, no interaction of 
l-THP with opioid receptors has been reported, and it analgesic effects 
are naloxone-independent (Hu and Jin, 1999). 
These interactions of l-THP with non-DA receptors, most notably 
its likely antagonism of alpha-1 adrenergic receptors and interaction 
with 5-HT1A receptors, may also contribute to its effects on cocaine 
seeking behavior and could mitigate some of the undesirable effects 
associated with DA receptor antagonism, thus further distinguishing l-
THP from other DA receptor antagonist drugs. Alpha-1 adrenergic 
(Zhang and Kosten, 2005) and 5-HT1A (Burmeister et al., 2004) 
receptor antagonists have been previously reported to attenuate 
cocaine seeking in rats. Secondary actions of l-THP at 5-HT1A and 
alpha adrenergic receptors could also minimize the extrapyramidal 
effects associated with DA receptor antagonism by l-THP (Imaki et al., 
2009; Kalkman et al., 1998; Millan et al., 2000; Wadenberg, 1996). 
4.6. Sedative effects of l-THP 
The effectiveness of DA antagonists for the treatment of cocaine 
addiction has been limited by problematic side effects, including motor 
impairment/sedation and anhedonia, attributable in part to undesirable 
pharmacological profiles (Platt et al., 2002). Additionally, the primary 
clinical feature of overdose intoxication with l-THP-containing 
preparations (which also typically contain a number of other 
pharmacologically active constituents) is central nervous system 
depression (Horowitz et al., 1996). To ensure that motor impairment 
did not contribute to the observed effects on reinstatement and to 
demonstrate dose separation between the toxic and therapeutic effects 
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of l-THP, we tested rats for non-specific motor impairment at the same 
doses used for reinstatement testing. Consistent with previous findings 
with ip l-THP (Mantsch et al., 2007; Xi et al., 2007), we found that, 
although l-THP produced dose-dependent motor impairment, as 
demonstrated by reductions in baseline extinction and food-reinforced 
responding, effects on reinstatement were observed at an l-THP dose 
(i.e., 3 mg/kg) that had no effects on lever-pressing during the food or 
extinction sessions. 
Although we assume that the behavioral suppression observed 
at the higher (i.e., 10 mg/kg) l-THP dose was primarily attributable to 
high-dose sedative effects, it is possible that aversive effects may 
have also contributed. l-THP, at higher doses, has been reported to 
increase thresholds for ICSS (Xi et al., 2007) and to reduce the 
breaking point for non-drug (sucrose sweetened) reinforcement under 
a progressive ratio schedule (Mantsch et al., 2010). However, in both 
cases, these effects, which potentially reflect anhedonia, emerged at 
doses higher than those at which effects on responses to cocaine were 
observed and may have been related to motor impairment. Further, l-
THP, at doses as high as 18.5 mg/kg (ip), does not produce 
conditioned place aversion (Liu et al., 2009) and anxiogenic effects of 
l-THP have not been reported. In fact, racemic (dl) THP has been 
reported to have anxiolytic properties (Leung et al., 2003) and l-THP 
containing preparations are often used for their sedative effects. Thus, 
we consider it to be unlikely that the general disruption of behavior 
observed at the higher l-THP dose was due to anxiogenic effects. 
Although approved for use in China, further preclinical and 
clinical examination of l-THP is needed to determine if it is safe enough 
for the US market and to distinguish from other DA antagonist drugs. 
4.7. Conclusions 
To summarize, orally administered l-THP was effective in 
preventing reinstatement by three different stimuli in a rat model of 
drug relapse at doses that did not produce measurable motor 
impairment. These findings add to a growing body of evidence 
suggesting that l-THP and other similar compounds derived from 
natural sources may themselves have medicinal value and/or may 
provide insight into desirable pharmacological profiles for future 
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medications. Although additional determination of the efficacy and 
safety of l-THP in human populations is necessary, our findings 
suggest that l-THP or l-THP containing preparations may have utility 
for facilitating relapse prevention and for the treatment of cocaine 
addiction. 
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